Measured Wealth Private Client Group, LLC

Position in ELAN — Elanco Animal Health Inc

CIK 1720235 PORTSMOUTH, NH

Back to ELAN Full portfolio

Position in ELAN

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$233,302

-$265,590 QoQ

Shares Held

9,480

-54.5% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

#362

of 518 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Common Shares in ELAN Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Measured Wealth Private Client Group, LLC holds $841,832 across 6 Drug Manufacturers - Specialty & Generic names. ELAN ranks #2 (27.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INDV	Indivior Pharmaceuticals, Inc.	13,398	$549,719
2	ELAN	Elanco Animal Health Inc This page	9,480	$233,302
3	NBIX	Neurocrine Biosciences Inc	140	$23,595
4	HLN	Haleon plc	1,997	$18,632
5	VTRS	Viatris Inc	533	$8,464
6	ZTS	Zoetis Inc.	113	$8,120

All Filings in ELAN

Export CSV

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$233,302	9,480	-54.5%	Shares	Sole	2026-08-10
2026-03-31	$498,892	20,848	+19.5%	Shares	Sole	2026-05-13
2025-12-31	$394,825	17,447	—	Shares	Sole	2026-02-10
No filing history on record for this holder in this stock.